M-201

N/A

Report date: 2025/11/30 20:00:10
NME

Base Information

Drug NameM-201
Drug Alias NameM-201-A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRyanodine receptor 3 modulatorsRyanodine receptor 2 modulatorsRyanodine receptor 1 modulators
TargetsRyanodine receptor 3Ryanodine receptor 2Ryanodine receptor 1
Therapy Area/IndicationsAtrial Fibrillation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAetas Pharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAetas Pharma Co LtdKitasato University
Active IndicationsN/A
Inactive IndicationsAtrial Fibrillation

Other Information

ATC CodeN/A
Related LinksN/A